This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Ezra M. Greenspan, MD; Ira Jaffrey, MD; Howard Bruckner, MD
Mount Sinai School of Medicine New York

JAMA. 1977;237(21):2288.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Allergic cutaneous reactions to systemic chemotherapeutic agents are well known, but the suggestion that such reactions might be beneficial has come only indirectly and from the topical use of alkylating agents and at least one cell-cycle-specific agent (fluorouracil) in the treatment of tumors in skin and soft tissues (Med Clin North Am 60:389-418, 1976).

In a retrospective review of our results of combination chemotherapy with thiotepa and methotrexate in 186 patients with stage III or IV ovarian cancer, ten survived free of disease more than three years after complete regression of previous advanced bulky metastases. Possible factors related to the clinical eradication of disease were sought. Seven patients had shown generalized cutaneous erythema, pruritus, and urticarial reactions of substantial proportions. These appeared one to three months after onset of the combination chemotherapy regimen and within one to 24 hours after thiotepa administration. Despite these reactions, treatment was . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?